- 30
- 73 535
PolyPeptide Group
Приєднався 15 лип 2020
PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide Group AG’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.
Peptide Manufacturing Rethinking the Technology Platform for Large Scale demand
Presented at TIDES Europe, November 13, 2024, speaker: Jan Pawlas.
The peptide market is strongly impacted by the evolution of the development pipeline, in particular for the treatments that require massive volumes of drugs, driven by the booming demand for metabolic diseases. The scale-up of the existing technology platform to produce synthetic peptides is a major challenge to reach the expected volumes. The current manufacturing technology platform needs to evolve in order to deliver both sustainable and cost-effective solutions. PolyPeptide is a leading CDMO organization, with the capabilities to efficiently adapt to the emerging requirements and to deliver the most effective and sustainable solutions to develop and manufacture your peptides.
The peptide market is strongly impacted by the evolution of the development pipeline, in particular for the treatments that require massive volumes of drugs, driven by the booming demand for metabolic diseases. The scale-up of the existing technology platform to produce synthetic peptides is a major challenge to reach the expected volumes. The current manufacturing technology platform needs to evolve in order to deliver both sustainable and cost-effective solutions. PolyPeptide is a leading CDMO organization, with the capabilities to efficiently adapt to the emerging requirements and to deliver the most effective and sustainable solutions to develop and manufacture your peptides.
Переглядів: 33
Відео
Novel Branching Method for Solid Phase Peptide Synthesis
Переглядів 2666 місяців тому
TIDES USA 2024 John Lee, Associate Director Innovation. At present, Polystyrene resin based solid phase peptide synthesis (SPPS) is the “go to” method for both research and industrial scale peptide syntheses. At industrial scale however, the current SPPS introduces major drawbacks; large reactor requirements and enormous amount of chemical wastes generated making synthetic peptides one of the m...
Study for the Novel Energy Efficient Approach for Reclaiming Acetonitrile in Peptide Manufacturing
Переглядів 1436 місяців тому
TIDES USA 2024 Brad Grossman, Head of Manufacturing, PolyPeptide Inc. In the past, acetonitrile has primarily been recovered by multistage distillations. While these can be effective, they also come with some processing limitations and challenges. An alternative pilot scale system has developed which demonstrates a new approach to recovering this critical solvent for peptide manufacturing and g...
Tailoring Control Strategies to Meet Specific Peptide Drug Substance Complexity
Переглядів 1116 місяців тому
TIDES USA 2024 Eran Benjamin, Global Director QC/AD Process analytical control strategies are built from the incoming starting material supply, process and purge capabilities, analytical control strategies, risk assessment tools and state of the art analytical methods. Different customers and regulatory agencies are requiring different levels of risk management and control. This presentation wi...
High-end Analytical Tools to Meet the Latest Regulatory Requirements for Generic Peptides
Переглядів 996 місяців тому
A Case Study TIDES USA 2024, Jean Marc Poudrel, Head of Regulatory Affairs at PolyPeptide SA While regulatory requirements for generic peptides applications are becoming more and more demanding, the existing analytical tools and techniques are pushed to their limits to deliver the appropriate performance (resolution, sensitivity, precision). This presentation will go through a recent case study...
Nous cherchons des Analystes Contrôle Qualité
Переглядів 958 місяців тому
Devenez le nouveau collègue de Matthias. Posez votre candidature via notre page Career Belgium: Devenez le nouveau collègue de Matthias. Posez votre candidature via notre page Career Belgium polypeptidebelgium.teamtailor.com/
PolyPeptide Braine-l'Alleud recrute
Переглядів 5488 місяців тому
Sacha - Electromécanicien de maintenance chez PolyPeptide raconte
PolyPeptide Braine-l'Alleud recrute
Переглядів 2808 місяців тому
Delphine - Technicienne de production chez PolyPeptide raconte
Interview with Trishul Shah PolyPeptide TIDES USA 2023
Переглядів 418Рік тому
Learn more about why PolyPeptide recently diversified into oligonucleotides manufacturing
Raw Material Control Strategy TIDES USA 2023, Eran Benjamin
Переглядів 534Рік тому
"Raw Material Control Strategy" Presented at TIDES USA, 2023, by Eran Benjamin, Global Director of Quality Control and Analytical Development
Process Development and Control Strategy for an Efficient Large Scale Manufacturing Process
Переглядів 1 тис.Рік тому
Presented by El Djouhar Rekai, Head of Process Development & Manufacturing Life Cycle Management at TIDES USA, 2023. Process and analytical development in peptide pharmaceutical industries are the key foundations to build an in-depth process understanding allowing to set the best control strategy of peptide manufacturing processes. Throughout the scale-up manufacturing process, the robustness o...
Overcoming oligonucleotide manufacturing challenges, Trishul Shah, TIDES USA 2023
Переглядів 320Рік тому
Trishul Shah is the Director of Business Development and Head of North American Sales. In this presentation at TIDES USA 2023, he gives an overview of the oligonucleotides-based therapeutics market and discusses how to overcome the oligonucleotides manufacturing challenges.
Chemical strategies in extending half-lives of therapeutic peptides, El Djouhar Rekai, TIDES ASIA
Переглядів 561Рік тому
Therapeutic peptides have been proven to be very effective in treating critical human diseases. Their number on the pharmaceutical market has significantly increased over the past two decades. Thanks to the chemical modification strategies offering to significantly extend their half live and to overcome the biggest challenge of fast degradation in serum. This presentation gives examples of chem...
Developing the Toolbox for Sustainable Peptide Manufacturing, Jon Holbech Rasmussen , TIDES ASIA
Переглядів 577Рік тому
The need for sustainable manufacturing practices is a major challenge for the worldwide industry, and the pharma world is increasingly engaged in this important green transformation. For the synthesis of peptide APIs, where large amounts of hazardous waste is generated and atom efficiency is challenged, new manufacturing concepts is a necessity. The presentation will show how PolyPeptide Group ...
Overcoming Oligonucleotide Manufacturing Challenges, Loïc Cornelissen, TIDES ASIA
Переглядів 837Рік тому
The Oligonucleotide CMO industry faces a number of challenges - Demand out pacing capacity for manufacturing, available expertise, high solvent and waste usage to name a few. The PolyPeptide Group established its OLIGO@POLYPEPTIDE division to help address some of these challenges and bring much needed medicine to patients. We discuss how PolyPeptide has leveraged its expertise in peptide manufa...
From 10 grams to several hundred - A case study in peptide GMP process development
Переглядів 2,8 тис.2 роки тому
From 10 grams to several hundred - A case study in peptide GMP process development
2 minutes with Raymond De Vré, CEO, PolyPeptide Group
Переглядів 2872 роки тому
2 minutes with Raymond De Vré, CEO, PolyPeptide Group
PolyPeptide Group - Ahead on green peptide chemistry
Переглядів 2,8 тис.2 роки тому
PolyPeptide Group - Ahead on green peptide chemistry
PolyPeptide Innovation and Technology
Переглядів 1,8 тис.4 роки тому
PolyPeptide Innovation and Technology
You haven’t explained it. Rather you showed nonsense and I would say, it is commercial and delusion.
Världens bästa företag 🎉
So whats the price, 😊
Excellent presentation madam.very nicely elucidated the chemical modifications leading to the stability of peptides. Otherwise they r unstable. Even SPPS methods for the yield using several options including Click chemistry was well explained you r having good knowledge on peptdes and their therapeutic pitential. pl continue serving humanity. May God bestow on you strength, tolerance and love..
All drugs r safe seeeee idiots
Is there one in Australia?
Very nice welcome video !
Congratulations on your efforts to make innovative products that making Life simpler, Sir. Regards from India 🙏
thanks for this! i’ve watched loads of face mask videos and they put in the peptide and i never knew what is was
Are those videos from this guy who goes by the name skincareryan ?
Maranatha.
Ugh. A commercial. No thanks.
þrðmð§m 😕
Thanks for nothing. "a peptide is basically a commercial for our company, the end."
Right, literally one sentence about what a peptide is
Fantastic company!